Literature DB >> 24594018

Dissociation of tolerance and nicotine withdrawal-associated deficits in contextual fear.

Thomas J Gould1, Derek S Wilkinson2, Emre Yildirim2, Julie A Blendy3, Michael D Adoff2.   

Abstract

Nicotine addiction is associated with the development of tolerance and the emergence of withdrawal symptoms upon cessation of chronic nicotine administration. Changes in cognition, including deficits in learning, are one of the most common withdrawal symptoms reported by smokers. However, the neural substrates of tolerance to the effects of nicotine on learning and the substrates of withdrawal deficits in learning are unknown, and in fact it is unclear whether a common mechanism is involved in both. The present study tested the hypothesis that tolerance and withdrawal are separate processes and that nicotinic acetylcholine receptor (nAChR) upregulation underlies changes in learning associated with withdrawal but not tolerance. C57BL/6 male mice were administered a dose of nicotine (3, 6.3, 12, or 24 mg/kg/d) chronically for varying days and tested for the onset of tolerance to the effects of nicotine on learning. Follow up experiments examined the number of days of chronic nicotine treatment required to produce withdrawal deficits in learning and a significant increase in [(3)H] epibatidine binding in the hippocampus indicative of receptor upregulation. The results indicate that tolerance onset was influenced by dose of chronic nicotine, that tolerance occurred before withdrawal deficits in learning emerged, and that nAChR upregulation in the dorsal hippocampus was associated with withdrawal but not tolerance. This suggests that for the effects of nicotine on learning, tolerance and withdrawal involve different substrates. These findings are discussed in terms of implications for development of therapeutics that target symptoms of nicotine addiction and for theories of addiction.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acetylcholine; Addiction; Cognition; Learning; Receptor binding; Withdrawal

Mesh:

Substances:

Year:  2014        PMID: 24594018      PMCID: PMC4000688          DOI: 10.1016/j.brainres.2014.02.038

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  70 in total

1.  The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation.

Authors:  Thomas J Gould; George S Portugal; Jessica M André; Matthew P Tadman; Michael J Marks; Justin W Kenney; Emre Yildirim; Michael Adoff
Journal:  Neuropharmacology       Date:  2012-01-21       Impact factor: 5.250

2.  Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.

Authors:  Roger L Papke; Caryn Trocmé-Thibierge; Daniela Guendisch; Shehd Abdullah Abbas Al Rubaiy; Stephen A Bloom
Journal:  J Pharmacol Exp Ther       Date:  2011-02-01       Impact factor: 4.030

3.  Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline.

Authors:  Jill R Turner; Laura M Castellano; Julie A Blendy
Journal:  Nicotine Tob Res       Date:  2010-11-22       Impact factor: 4.244

4.  Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.

Authors:  Jill R Turner; Laura M Castellano; Julie A Blendy
Journal:  J Pharmacol Exp Ther       Date:  2010-04-30       Impact factor: 4.030

5.  Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning.

Authors:  George S Portugal; Derek S Wilkinson; Justin W Kenney; Colleen Sullivan; Thomas J Gould
Journal:  Behav Genet       Date:  2011-08-06       Impact factor: 2.805

6.  Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.

Authors:  James Loughead; Riju Ray; E Paul Wileyto; Kosha Ruparel; Paul Sanborn; Steven Siegel; Ruben C Gur; Caryn Lerman
Journal:  Biol Psychiatry       Date:  2010-03-06       Impact factor: 13.382

7.  Short- and long-lasting consequences of in vivo nicotine treatment on hippocampal excitability.

Authors:  Rachel E Penton; Michael W Quick; Robin A J Lester
Journal:  J Neurosci       Date:  2011-02-16       Impact factor: 6.167

Review 8.  Mechanistic insights into nicotine withdrawal.

Authors:  Michael Paolini; Mariella De Biasi
Journal:  Biochem Pharmacol       Date:  2011-07-20       Impact factor: 5.858

9.  Meta-analysis of the acute effects of nicotine and smoking on human performance.

Authors:  Stephen J Heishman; Bethea A Kleykamp; Edward G Singleton
Journal:  Psychopharmacology (Berl)       Date:  2010-04-24       Impact factor: 4.530

10.  Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats.

Authors:  Edward D Levin; Amir H Rezvani; Yingxian Xiao; Susan Slade; Marty Cauley; Corinne Wells; Dawn Hampton; Ann Petro; Jed E Rose; Milton L Brown; Mikell A Paige; Brian E McDowell; Kenneth J Kellar
Journal:  J Pharmacol Exp Ther       Date:  2009-12-10       Impact factor: 4.030

View more
  17 in total

1.  Nicotine Addiction and Psychiatric Disorders.

Authors:  Munir Gunes Kutlu; Vinay Parikh; Thomas J Gould
Journal:  Int Rev Neurobiol       Date:  2015-09-19       Impact factor: 3.230

2.  In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.

Authors:  Asti Jackson; Deniz Bagdas; Pretal P Muldoon; Aron H Lichtman; F Ivy Carroll; Mark Greenwald; Michael F Miles; M Imad Damaj
Journal:  Neuropharmacology       Date:  2017-03-07       Impact factor: 5.250

3.  ABT-089, but not ABT-107, ameliorates nicotine withdrawal-induced cognitive deficits in C57BL6/J mice.

Authors:  Emre Yildirim; David A Connor; Thomas J Gould
Journal:  Behav Pharmacol       Date:  2015-04       Impact factor: 2.293

4.  Withdrawal From Chronic Nicotine Reduces Thyroid Hormone Levels and Levothyroxine Treatment Ameliorates Nicotine Withdrawal-Induced Deficits in Hippocampus-Dependent Learning in C57BL/6J Mice.

Authors:  Prescott T Leach; Erica Holliday; Munir G Kutlu; Thomas J Gould
Journal:  Nicotine Tob Res       Date:  2014-10-30       Impact factor: 4.244

5.  Stress and nicotine during adolescence disrupts adult hippocampal-dependent learning and alters stress reactivity.

Authors:  Erica D Holliday; Sheree F Logue; Chicora Oliver; Debra A Bangasser; Thomas J Gould
Journal:  Addict Biol       Date:  2019-05-16       Impact factor: 4.280

Review 6.  Glial cells as therapeutic targets for smoking cessation.

Authors:  Mohit Kumar; Adewale Adeluyi; Erin L Anderson; Jill R Turner
Journal:  Neuropharmacology       Date:  2020-05-24       Impact factor: 5.250

Review 7.  Nicotine, adolescence, and stress: A review of how stress can modulate the negative consequences of adolescent nicotine abuse.

Authors:  Erica Holliday; Thomas J Gould
Journal:  Neurosci Biobehav Rev       Date:  2016-04-08       Impact factor: 8.989

Review 8.  Nicotine modulation of fear memories and anxiety: Implications for learning and anxiety disorders.

Authors:  Munir Gunes Kutlu; Thomas J Gould
Journal:  Biochem Pharmacol       Date:  2015-07-29       Impact factor: 5.858

9.  Impairment of contextual fear extinction by chronic nicotine and withdrawal from chronic nicotine is associated with hippocampal nAChR upregulation.

Authors:  Munir Gunes Kutlu; Chicora Oliver; Peng Huang; Lee-Yuan Liu-Chen; Thomas J Gould
Journal:  Neuropharmacology       Date:  2016-07-01       Impact factor: 5.250

10.  Cognitive rigidity and BDNF-mediated frontostriatal glutamate neuroadaptations during spontaneous nicotine withdrawal.

Authors:  Robert D Cole; Matty Zimmerman; Anastasia Matchanova; Munir Gunes Kutlu; Thomas J Gould; Vinay Parikh
Journal:  Neuropsychopharmacology       Date:  2019-11-21       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.